Total Holdings
25
Portfolio diversification across 25 positions
BBH
(NASDAQ)VanEck Biotech ETF
$204.03-- (--)
Loading... - Market loading
BBH ETF Holdings: VanEck Biotech ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$365.74M
Total fund assets
Expense Ratio
0.35%
Annual management fee
Fund Issuer
VanEck
Nasdaq Stock Market
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 26 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Amgen Inc. | Stock | 14.48% |
| 2 |  | Gilead Sciences, Inc | Stock | 14.30% |
| 3 |  | Vertex Pharmaceuticals Incorporated | Stock | 8.13% |
| 4 |  | argenx SE | Stock | 6.39% |
| 5 |  | Regeneron Pharmaceuticals, Inc | Stock | 6.04% |
| 6 |  | Revolution Medicines, Inc. | Stock | 4.71% |
| 7 |  | IQVIA Holdings Inc | Stock | 4.56% |
| 8 |  | Natera, Inc. | Stock | 4.32% |
| 9 |  | Biogen Inc. | Stock | 4.03% |
| 10 |  | Alnylam Pharmaceuticals, Inc | Stock | 3.79% |
| 11 |  | United Therapeutics Corporation | Stock | 3.61% |
| 12 |  | Illumina, Inc. | Stock | 3.37% |
| 13 |  | Moderna, Inc. | Stock | 3.18% |
| 14 | B BGNE | BeiGene, Ltd | Stock | 3.18% |
| 15 |  | Insmed Incorporated | Stock | 3.04% |
| 16 |  | BeOne Medicines AG | Stock | 2.93% |
| 17 |  | Incyte Corporation | Stock | 2.44% |
| 18 |  | Neurocrine Biosciences, Inc. | Stock | 2.34% |
| 19 |  | BioNTech SE | Stock | 2.27% |
| 20 |  | ICON Public Limited Company | Stock | 1.70% |
| 21 |  | Bio-Techne Corporation | Stock | 1.45% |
| 22 |  | Charles River Laboratories International, Inc. | Stock | 1.40% |
| 23 |  | BioMarin Pharmaceutical Inc. | Stock | 1.37% |
| 24 |  | Tempus AI, Inc. | Stock | 1.07% |
| 25 |  | Qiagen N.V. | Stock | 1.06% |
| 26 | E ETR:QIA | QIAGEN N.V | Stock | 1.05% |
Frequently Asked Questions About VanEck Biotech ETF Holdings
What are the top holdings in BBH?
VanEck Biotech ETF (BBH) holds 25 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is BBH's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review BBH's holdings table to analyze concentration risk.
What is BBH's sector allocation?
The Sector Allocation chart shows how BBH distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does BBH invest in?
BBH's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is BBH ETF?
BBH's diversification can be assessed by reviewing its 25 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.